arrow
返回

Exercise interventions for smoking cessation

delete2019-10-30
delete75
delete
OA
AI
M
Michael Ussher *
G
Guy Faulkner
K
Kathryn Angus
J
Jamie Hartmann‐Boyce
A
Adrian Taylor
DOI:10.1002/14651858.CD002295.pub6delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Background Taking regular exercise, whether cardiovascular-type exercise or resistance exercise, may help people to give up smoking, particularly by reducing cigarette withdrawal symptoms and cravings, and by helping to manage weight gain. Objectives To determine the effectiveness of exercise-based interventions alone, or combined with a smoking cessation programme, for achieving long-term smoking cessation, compared with a smoking cessation intervention alone or other non-exercise intervention. Search methods We searched the Cochrane Tobacco Addiction Group Specialised Register for studies, using the term 'exercise' or 'physical activity' in the title, abstract or keywords. The date of the most recent search was May 2019. Selection criteria We included randomised controlled trials that compared an exercise programme alone, or an exercise programme as an adjunct to a cessation programme, with a cessation programme alone or another non-exercise control group. Trials were required to recruit smokers wishing to quit or recent quitters, to assess abstinence as an outcome and have follow-up of at least six months. Data collection and analysis We followed standard Cochrane methods. Smoking cessation was measured after at least six months, using the most rigorous definition available, on an intention-to-treat basis. We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for smoking cessation for each study, where possible. We grouped eligible studies according to the type of comparison, as either smoking cessation or relapse prevention. We carried out meta-analyses where appropriate, using Mantel-Haenszel random-effects models. Main results We identified 24 eligible trials with a total of 7279 adult participants randomised. Two studies focused on relapse prevention among smokers who had recently stopped smoking, and the remaining 22 studies were concerned with smoking cessation for smokers who wished to quit. Eleven studies were with women only and one with men only. Most studies recruited fairly inactive people. Most of the trials employed supervised, group-based cardiovascular-type exercise supplemented by a home-based exercise programme and combined with a multi-session cognitive behavioural smoking cessation programme. The comparator in most cases was a multi-session cognitive behavioural smoking cessation programme alone. Overall, we judged two studies to be at low risk of bias, 11 at high risk of bias, and 11 at unclear risk of bias. Among the 21 studies analysed, we found low-certainty evidence, limited by potential publication bias and by imprecision, comparing the effect of exercise plus smoking cessation support with smoking cessation support alone on smoking cessation outcomes (RR 1.08, 95% Cl 0.96 to 1.22; I-2 = 0%; 6607 participants). We excluded one study from this analysis as smoking abstinence rates for the study groups were not reported. There was no evidence of subgroup differences according to the type of exercise promoted; the subgroups considered were: cardiovascular-type exercise alone (17 studies), resistance training alone (one study), combined cardiovascular-type and resistance exercise (one study) and type of exercise not specified (two studies). The results were not significantly altered when we excluded trials with high risk of bias, or those with special populations, or those where smoking cessation intervention support was not matched between the intervention and control arms. Among the two relapse prevention studies, we found very low-certainty evidence, limited by risk of bias and imprecision, that adding exercise to relapse prevention did not improve long-term abstinence compared with relapse prevention alone (RR 0.98, 95% CI 0.65 to 1.47; I-2 = 0%; 453 participants). Authors' conclusions There is no evidence that adding exercise to smoking cessation support improves abstinence compared with support alone, but the evidence is insufficient to assess whether there is a modest benefit. Estimates of treatment effect were of low or very low certainty, because of concerns about bias in the trials, imprecision and publication bias. Consequently, future trials may change these conclusions.
Keyword:
Cognitive Behavioral Therapy
Exercise
Randomized Controlled Trials as Topic
Recurrence
Smoking [psychology] [*therapy]
Smoking Cessation [*methods]
Weight Gain
Humans
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Cochrane Database of Systematic Reviews 封面图
Cochrane Database of Systematic Reviews
IF:
9.4
论文数:
1.3W
被引数:
7.9W

机构

U
University of Stirling
学者数:
3.7K
论文数: 4.2K
被引数: 5.8K
U
university of oxford
学者数:
9.8W
论文数: 8.6W
被引数: 137
S
St Georges University London
学者数:
4.8K
论文数: 3.7K
被引数: 28
C
city st georges, university of london
学者数:
1.2W
论文数: 1.1W
被引数: 12
U
University of British Columbia
学者数:
7.0W
论文数: 6.1W
被引数: 8.6W
学者 查看更多机构
引用论文

引用论文

Exercise effects on withdrawal and mood among women attempting smoking cessation
err1999-05-01
err120
PREAI
errBock, BC; Marcus, BH; King, TK; Borrelli, B; Roberts, MR
err分享
err收藏
Smoking Cessation Program with Exercise Improves Cardiovascular Disease Biomarkers in Sedentary Women
err2011-07-01
err35
errOAAI
errKorhonen, Tellervo; Goodwin, Amy; Miesmaa, Petra; Dupuis, Elizabeth A.; Kinnunen, Taru
err分享
err收藏
NADPH oxidation catalyzed by the peroxidase/H2O2 system
err2005-03-03
err0
errOAAI
errAlain VIRION; Jean Luc MICHOT; Danièle DEME; Jacques POMMIER
err分享
err收藏
Nonparametric Bayesian Clustering Ensembles
err2010-01-01
err0
errOAAI
errPu Wang; Carlotta Domeniconi; Kathryn Blackmond Laskey
err分享
err收藏
Challenges and Limitations of Karst Aquifer Vulnerability Mapping Based on the PaPRIKa Method—Application to a Large European Karst Aquifer (Fontaine de Vaucluse, France)
err2019-03-26
err0
errOAAI
errChloé Ollivier; Konstantinos Chalikakis; Naomi Mazzilli; Nerantzis Kazakis; Yoann Lecomte; Charles Danquigny; Christophe Emblanch
err分享
err收藏
Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models
err2011-01-01
err0
PREAI
errEugen F. Mesaros; Jason P. Burke; Jonathan D. Parrish; Benjamin J. Dugan; Andrew V. Anzalone; Thelma S. Angeles; Mark S. Albom; Lisa D. Aimone; Matthew R. Quail; Weihua Wan; Lihui Lu; Zeqi Huang; Mark A. Ator; Bruce A. Ruggeri; Mangeng Cheng; Gregory R. Ott; Bruce D. Dorsey
err分享
err收藏
学者 查看更多内容